ADC Therapeutics CFO Jose Carmona Receives 203,700 RSUs Valued at $0 Per Share

This Form 4 filing reports that Jose Carmona, Chief Financial Officer of ADC Therapeutics SA, received 203,700 restricted stock units (RSUs) on June 30, 2026. The RSUs were granted at $0 per share as part of an incentive award. The RSUs will vest on the earlier of June 30, 2027 or termination of employment by the company without cause or by Carmona for good reason, subject to continued employment. Following this transaction, Carmona's total holdings in ADC Therapeutics common shares increased to 938,076 shares. The filing was signed by Lisa Kallebo as attorney-in-fact for Jose Carmona on July 2, 2026. This represents a significant equity compensation award to the company's CFO.